- Home
- ABVC vs LOAN Comparison
ABVC vs LOAN Comparison
Compare ABVC & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABVC | LOAN |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.6M | 51.9M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | ABVC | LOAN |
|---|---|---|
| Price | $2.27 | $4.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 82.1K | 41.0K |
| Earning Date | 11-03-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 10.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $797,916.00 | ★ $7,138,128.00 |
| Revenue This Year | $735.18 | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $9.83 |
| Revenue Growth | ★ 56.52 | N/A |
| 52 Week Low | $0.40 | $4.29 |
| 52 Week High | $5.48 | $6.05 |
Technical Indicators
Market Signals| Indicator | ABVC | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 33.04 |
| Support Level | $2.05 | $4.45 |
| Resistance Level | $2.43 | $4.71 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 58.51 | 10.69 |
Price Performance
Historical ComparisonAbout ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.